Evidence map›Paper›PMID 28264065›Full record

ArticlePloS one2017

Maternal cancer and congenital anomalies in children - a Danish nationwide cohort study.

Natalie C Momen, Andreas Ernst, Linn Håkonsen Arendt, Jørn Olsen, Jiong Li, Mika Gissler, Finn Rasmussen, Cecilia Høst Ramlau-Hansen

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Natalie C MomenDepartment of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark.
Andreas ErnstDepartment of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark.
Linn Håkonsen ArendtDepartment of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark.
Jørn OlsenDepartment of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Jiong LiDepartment of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Mika GisslerTHL National Institute for Health and Welfare, Helsinki, Finland.
Finn RasmussenDepartment of Health Sciences, Lund University, Lund, Sweden.
Cecilia Høst Ramlau-HansenDepartment of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark.
Aarhus University · DKAarhus University Hospital · DKFinnish Institute for Health and Welfare · FILund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several studies on pregnancy-associated cancers have suggested an association with congenital anomalies in offspring. Previous studies have included maternal cancers diagnosed up to 2 years after pregnancy; however, long latency periods of some cancers mean that cancers diagnosed many years postpartum might have been present during pregnancy in a preclinical state. This paper considers the association between maternal cancers diagnosed from 2 years prior to pregnancy until the mother reaches 50 years of age, and congenital anomalies, as diagnosed at birth or within the first year of life. The current population-based study looks at associations of cancers in mothers with congenital anomalies in their children. Children were followed up from birth to diagnosis of a congenital anomaly, death, emigration or end of follow-up (whichever occurred first). A total of 56,016 children (2.6%) were considered exposed to a maternal cancer of any type; and they had a hazard ratio (HR) of 1.04 (95% confidence interval [CI]: 1.00, 1.09) compared with unexposed children. The greatest HR was seen among children whose mothers had been diagnosed with cancers before or during pregnancy (HR: 1.37, 95% CI: 1.07, 1.75). Similar results were seen when paternal cancers were used as a 'negative control'. Statistically significant associations were seen for some specific congenital anomalies of organ systems (congenital anomalies of the musculoskeletal system [HR: 1.13, 95% CI: 1.02, 1.25]) and for some specific types of maternal cancer (leukaemia [HR: 1.31, 95% CI: 1.01, 1.61], The results of the main analyses suggest a small increase in risk of congenital anomalies in offspring of mothers diagnosed with cancer from 2 years before pregnancy, until the mother reaches 50 years of age; with the greatest increase seen for exposure in the pre-pregnancy and pregnancy period. These results may reflect shared causes for some cancers and some congenital anomalies. The similar results seen for paternal cancers indicate that the cause may be genetic or related to the families' social and environmental conditions.

Indexed as

Pregnancy Complications, NeoplasticPrenatal Exposure Delayed EffectsAdultChildCohort StudiesCongenital AbnormalitiesDenmarkFemaleHumansMaleMiddle AgedNeoplasmsPregnancyProportional Hazards ModelsRegistriesRisk

Identifiers

PMID28264065
PMCPMC5338803
OpenAlexW2612492898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.